Company
ChinaNational Beijing Center For Drug Safety Evaluation And Resea, Beijing, China – FDA Inspections
Inspection records and compliance data for National Beijing Center For Drug Safety Evaluation And Resea in Beijing. 1 FDA inspection on record, 1 Form 483, last inspected April 28, 2017.
Company Profile
This profile covers National Beijing Center For Drug Safety Evaluation And Resea based in Beijing, China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected April 28, 2017.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 28, 2017 | Not classified | Human Drugs | 1026730 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Weibo Yang
Hebei Donghua Jiheng Aminoacid Sci.&Tec. Co.,Ltd
Keng Shen M.D. Peking Union Medical College Hospital
Zhejiang Bangli Medical Products Co., Ltd
Yinjing Medical Technology (Shanghai) Co., Ltd.
Xiaozhong Chen
Cixi Zhixin Bird Clean-Care Product Co., Ltd.
Fuan Pharmaceutical Group Chongqing Bosen Pharma. Co., LTD
Zhejiang Xianju Xianming Pharmaceutical Co., Ltd.
Zhongjun Xia, MD
Company Information
Name
National Beijing Center For Drug Safety Evaluation And Resea
FEI Number
3005135006
Address
27 Taiping Road, Haidan District, Beijing, China
Country
China
ID: 76c62777-b5a9-4194-acc8-0f4bb0ddd3aa